Literature DB >> 23377820

Does pantoprazole protect against reperfusion injury following myocardial ischemia in rats?

A Bacaksiz1, M E Teker, N Buyukpinarbasili, O Inan, A Tasal, O Sonmez, E Erdogan, M Turfan, O C Akdemir, G Ertas.   

Abstract

BACKGROUND: Myocardial ischemia is inadequate perfusion due to reduced blood flow. Sudden onset of reperfusion could result with damage to the myocytes that have not been affected during ischemia called ischemia reperfusion (I/R) injury. Extracellular accumulation of H+ ions resulting in tissue acidosis is one of the underlying mechanisms. Inhibition of myocardial H+/K+-ATPase, namely proton pump, may lead to intracellular acidification via decreasing the extracellular H+ transport. AIM: The aim of this study is to investigate the effects of a proton pump inhibitor pantoprazole in intact rat I/R models.
MATERIALS AND METHODS: A total of 30 adult male Wistar albino rats weighing 200-300 g were studied. Rats were allocated into four groups: sham (n=6), ischemia (n=8), control (n=8), and pantoprazole (n=8). Left anterior descending coronary artery was occluded for 30 minutes and then reperfused for two hours. Pantoprazole was administered via jugular vein at the dose of 9 mg/kg starting from 30 minutes before ischemia, to the first 30 minutes of reperfusion. Haemodynamic parameters were recorded and serum CK-MB levels were measured. After reperfusion, heart was removed for the measurement of myocardial infarct size. Myocardial infarct area was measured using triphenyltetrazolium chloride (TTC) staining technique. Myocardial infarction size were expressed as the percentage of the total left ventricular weight.
RESULTS: Compared with other groups, plasma concentrations of CK-MB at the end of ischemia and reperfusion and myocardial infarct size were significantly lower in pantoprazole group (p < 0.008).
CONCLUSIONS: Pantoprazole preconditioning induces delayed cardioprotection in intact rat I/R model, which may be triggered via H+/K+-ATPase ion channels.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23377820

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  4 in total

1.  Berberine Protests the Heart from Ischemic Reperfusion Injury via Interference with Oxidative and Inflammatory Pathways.

Authors:  Abeer Abdulredha; Munther Abosaooda; Fadhil Al-Amran; Najah R Hadi
Journal:  Med Arch       Date:  2021-06

2.  Effects of ischemia and omeprazole preconditioning on functional recovery of isolated rat heart.

Authors:  Nevena Jeremic; Anica Petkovic; Ivan Srejovic; Vladimir Zivkovic; Dragan Djuric; Vladimir Jakovljevic
Journal:  Rev Bras Cir Cardiovasc       Date:  2015 Mar-Apr

3.  Protective effects of fisetin against myocardial ischemia/reperfusion injury.

Authors:  Lihui Long; Xuliang Han; Xingming Ma; Kai Li; Linjie Liu; Juanni Dong; Bei Qin; Kelin Zhang; Kuan Yang; Honglin Yan
Journal:  Exp Ther Med       Date:  2020-03-06       Impact factor: 2.447

4.  Elevated perfusate [Na+] increases contractile dysfunction during ischemia and reperfusion.

Authors:  D Ryan King; Rachel L Padget; Justin Perry; Gregory Hoeker; James W Smyth; David A Brown; Steven Poelzing
Journal:  Sci Rep       Date:  2020-10-14       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.